335 related articles for article (PubMed ID: 19355902)
1. Toxic, immunostimulatory and antagonist gluten peptides in celiac disease.
Silano M; Vincentini O; De Vincenzi M
Curr Med Chem; 2009; 16(12):1489-98. PubMed ID: 19355902
[TBL] [Abstract][Full Text] [Related]
2. Coeliac disease: immunogenicity studies of barley hordein and rye secalin-derived peptides.
Wahab WA; Šuligoj T; Ellis J; Côrtez-Real B; Ciclitira PJ
Int J Exp Pathol; 2016 Aug; 97(4):303-309. PubMed ID: 27659035
[TBL] [Abstract][Full Text] [Related]
3. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
4. Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.
Silano M; Vincentini O; Iapello A; Mancini E; De Vincenzi M
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S191-2. PubMed ID: 18685513
[TBL] [Abstract][Full Text] [Related]
5. The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues.
Pinier M; Fuhrmann G; Galipeau HJ; Rivard N; Murray JA; David CS; Drasarova H; Tuckova L; Leroux JC; Verdu EF
Gastroenterology; 2012 Feb; 142(2):316-25.e1-12. PubMed ID: 22079593
[TBL] [Abstract][Full Text] [Related]
6. In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.
Lindfors K; Rauhavirta T; Stenman S; Mäki M; Kaukinen K
Exp Biol Med (Maywood); 2012 Feb; 237(2):119-25. PubMed ID: 22282398
[TBL] [Abstract][Full Text] [Related]
7. Ingestion of oats and barley in patients with celiac disease mobilizes cross-reactive T cells activated by avenin peptides and immuno-dominant hordein peptides.
Hardy MY; Tye-Din JA; Stewart JA; Schmitz F; Dudek NL; Hanchapola I; Purcell AW; Anderson RP
J Autoimmun; 2015 Jan; 56():56-65. PubMed ID: 25457306
[TBL] [Abstract][Full Text] [Related]
8. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
9. Despite sequence homologies to gluten, salivary proline-rich proteins do not elicit immune responses central to the pathogenesis of celiac disease.
Tian N; Leffler DA; Kelly CP; Hansen J; Marietta EV; Murray JA; Schuppan D; Helmerhorst EJ
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(11):G910-7. PubMed ID: 26505973
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of clinical and immune reactivity to barley and rye ingestion in children with coeliac disease.
Hardy MY; Russell AK; Pizzey C; Jones CM; Watson KA; La Gruta NL; Cameron DJ; Tye-Din JA
Gut; 2020 May; 69(5):830-840. PubMed ID: 31462555
[TBL] [Abstract][Full Text] [Related]
11. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.
Lundin KE; Scott H; Hansen T; Paulsen G; Halstensen TS; Fausa O; Thorsby E; Sollid LM
J Exp Med; 1993 Jul; 178(1):187-96. PubMed ID: 8315377
[TBL] [Abstract][Full Text] [Related]
12. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
[TBL] [Abstract][Full Text] [Related]
13. Celiac disease: from gluten to autoimmunity.
Briani C; Samaroo D; Alaedini A
Autoimmun Rev; 2008 Sep; 7(8):644-50. PubMed ID: 18589004
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease: epidemiology, pathogenesis, diagnosis, and nutritional management.
Schuppan D; Dennis MD; Kelly CP
Nutr Clin Care; 2005; 8(2):54-69. PubMed ID: 16013224
[TBL] [Abstract][Full Text] [Related]
15. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
[TBL] [Abstract][Full Text] [Related]
16. The immune recognition of gluten in coeliac disease.
Ciccocioppo R; Di Sabatino A; Corazza GR
Clin Exp Immunol; 2005 Jun; 140(3):408-16. PubMed ID: 15932501
[TBL] [Abstract][Full Text] [Related]
17. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice.
Verdu EF; Huang X; Natividad J; Lu J; Blennerhassett PA; David CS; McKay DM; Murray JA
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G217-25. PubMed ID: 18006603
[TBL] [Abstract][Full Text] [Related]
18. Pathomechanisms in celiac disease.
Dieterich W; Esslinger B; Schuppan D
Int Arch Allergy Immunol; 2003 Oct; 132(2):98-108. PubMed ID: 14600421
[TBL] [Abstract][Full Text] [Related]
19. Management of celiac disease in daily clinical practice.
Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
[TBL] [Abstract][Full Text] [Related]
20. Celiac sprue.
Cárdenas A; Kelly CP
Semin Gastrointest Dis; 2002 Oct; 13(4):232-44. PubMed ID: 12462708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
